Eli Lilly boosts China footprint with US$3 billion plan to expand supply chain
Eli Lilly has pledged an additional US$3 billion investment in China over the next decade to strengthen its local supply chain and manufacturing capabilities, deepening the footprint of foreign pharmaceutical…